LigaSure™ Maryland Jaw Open and Laparoscopic Sealer/Divider with Nano-coating

We added nonstick nano-coating technology on the LigaSure™ Maryland jaw device to help you tackle challenges both big and small.

The new LigaSure™ Maryland jaw device is designed to help you treat patients — reliably and efficiently.^2,§

Because we combined the benefits of nonstick nano-coating technology with the predictable performance of LigaSure™ vessel-sealing technology.

Nano-coating is a highly controlled, thin-film coating with uniform thickness. It covers the entire jaws of a LigaSure™ device without impacting the intelligent vessel-sealing algorithms of Valleylab™ energy platforms.([FOOTNOTE=Based on internal test report #RE00070396 Rev A, Verification of the LF1923/LF1937/LF1944 Maryland devices in a renal bench burst study: iterations Maryland. Nov. 7–10, 2016.],[ANCHOR=],[LINK=])

Reduce sticking^3,‡ improve efficiency^2,§

For the LigaSure™ Maryland jaw device, compared to its uncoated counterpart, that means: 

• Less eschar buildup^2,††
• Less sticking^3,‡
• Fewer jaw cleanings^3,§

The net benefit is smoother, more efficient procedures.^2,§

The confidence of control and consistency

LigaSure™ technology has been setting the standard of care for vessel sealing for nearly two decades.

LigaSure™ technology uses the body’s own collagen and elastin to create a permanent seal that can withstand three times normal systolic blood pressure.([FOOTNOTE=Based on internal test report #R0064457, LigaSure™ device renal bench burst pressure evaluation of the Valleylab™ FT10 energy platform. May 3, 2015.],[ANCHOR=],[LINK=]) It’s been used in more than 19 million procedures worldwide.([FOOTNOTE=Based on internal report #US161132(1), Sales data from FY01 to FY17. July 2017.],[ANCHOR=],[LINK=])^,§§§ And is supported by an ever-growing body of clinical evidence.

With an average seal cycle of one to four seconds in most surgical situations,([FOOTNOTE=Based on internal test report #RE00025819 Rev A, LigaSure™ device data sources for VLFT10 white papers. September 2015.],[ANCHOR=],[LINK=]) LigaSure™ technology can seal vessels up to and including 7 mm, lymphatics, and tissue bundles. It also eliminates the guesswork — and minimises thermal spread([FOOTNOTE=Based on internal test report #RE00005503, Verification report: GLP acute animal lab: LigaSure™ device preclinical evaluation of Valleylab™ FT10 energy platform. May 19, 2015.],[ANCHOR=],[LINK=]) — by automatically discontinuing energy delivery when the seal cycle is complete.⁹

Made even better by the Valleylab™ FT10 energy platform

The LigaSure™ Maryland jaw portfolio works great when powered by the ForceTriad™ energy platform with 3.6 software and higher. For optimal performance, use it with the Valleylab™ FT10 energy platform.

The Valleylab™ FT10 energy platform makes LigaSure™ devices better than ever.^9,([FOOTNOTE=Based on internal test report #RE00005401 Rev A, Product validation of Valleylab™ FT10 energy platform: surgeon and nurse evaluation in simulated use. Jan. 27 to 30, 2015 and Feb. 24 to 27, 2015.],[ANCHOR=],[LINK=])